Zebetuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zebetuzumab, covering 2025-10-06 to 2025-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL [Phase 2]